Channeling and prevalence of cardiovascular contraindications in users of cyclooxygenase 2 selective nonsteroidal antiinflammatory drugs. Mosis, G., Stijnen, T., Castellsague, J., Dieleman, J. P., Van Der Lei, J., Stricker, B. H. C., & Sturkenboom, M. C. J. M. Arthritis Care and Research, 55(4):537-542 , DOI = 10.1002/art.22096, 2006.
Channeling and prevalence of cardiovascular contraindications in users of cyclooxygenase 2 selective nonsteroidal antiinflammatory drugs [link]Paper  bibtex   
@article{RN373,
   author = {Mosis, G. and Stijnen, T. and Castellsague, J. and Dieleman, J. P. and Van Der Lei, J. and Stricker, B. H. C. and Sturkenboom, M. C. J. M.},
   title = {Channeling and prevalence of cardiovascular contraindications in users of cyclooxygenase 2 selective nonsteroidal antiinflammatory drugs},
   journal = {Arthritis Care and Research},
   volume = {55},
   number = {4},
   pages = {537-542 , DOI = 10.1002/art.22096},
   url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-33747874024&doi=10.1002%2fart.22096&partnerID=40&md5=db961f1821cbe09a0b3f3ae9dc0a300d},
   year = {2006},
   type = {Journal Article}
}

Downloads: 0